Comparable stake leader
Rosalind Advisors, Inc.
SEC ownership of FENNEC PHARMACEUTICALS INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001211583.
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- FENC on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Rosalind Advisors, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Rosalind Advisors, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001211583
- Issuer location
- Research Triangle Park, NC
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of FENNEC PHARMACEUTICALS INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rosalind Advisors, Inc.
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.6%
13D/G row: Rosalind Advisors, Inc.
Showing 1-8 of 50 holder rows.
Quick read
Rosalind Advisors, Inc. leads the comparable SEC ownership view at 9.6%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rosalind Advisors, Inc.'s linked filing trail.
Comparable ownership
Top 5
Rosalind Advisors, Inc.
9.6%
Sonic Fund II, L.P.
8.2%
Orin Hirschman
5.7%
Solas Capital Management, LLC
5.4%
DG Capital Management, LLC
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. |
13D/G
13F
Company
|
9.6%
|
$35,704,330
3,321,333 shares
|
+$3,007,850 | 30 Jun 2026 |
| Sonic Fund II, L.P. |
13D/G
Kam Lawrence
|
8.2%
|
$21,503,685
2,799,959 shares
|
$0 | 31 Dec 2025 |
| Orin Hirschman |
13D/G
|
5.7%
|
$12,186,826
1,981,501 shares
|
$0 | 31 Mar 2026 |
| Solas Capital Management, LLC |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$20,310,685
1,889,366 shares
|
— | 30 Jun 2026 |
| DG Capital Management, LLC |
13D/G
|
4.1%
|
$6,342,597
1,114,692 shares
|
$0 | 31 Dec 2024 |
| Southpoint Capital Advisors LP |
3/4/5
10%+ Owner
|
7.8%
|
$20,585,557
2,744,741 shares
|
-$10,341,902 | 24 Dec 2025 |
| AIGH Capital Management LLC |
13F
Company
|
7.1%
|
$26,724,908
2,486,038 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
4.9%
|
$18,565,992
1,727,069 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$12,493,273.
Buys
$0
Insiders: 0
Sells
$12,493,273
Insiders: 5
Net
-$12,493,273
Shares: -1,551,407
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 1,551,407
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 116,599 | $0 | $1,346,486 | -$1,346,486 |
| 3-6 | 0 | 39,820 | $0 | $291,344 | -$291,344 |
| 6-9 | 0 | 1,030,740 | $0 | $7,742,940 | -$7,742,940 |
| 9-12 | 0 | 364,248 | $0 | $3,112,503 | -$3,112,503 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to FENNEC PHARMACEUTICALS INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
Southpoint Capital Advisors LP
Net 12M change
-$12,493,273
Latest report
31 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 10%+ Owner | $20,585,557 | -$10,341,902 | -33% | Filing P/S | 24 Dec 2025 |
| Robert Andrade | Chief Financial Officer | $5,915,636 | -$883,500 | -13% | Mixed | 31 Aug 2026 |
| Rosty Raykov | Former Director | $5,395,722 | -$1,046,554 | -16% | Mixed | 31 Aug 2026 |
| Jeffrey S. Hackman | Chief Executive Officer, Director | $2,124,996 | Mixed | 31 Aug 2026 | ||
| Chris A. Rallis | Director | $2,024,262 | -$75,157 | -3.6% | Mixed | 10 Jun 2026 |
| Khalid Islam | Director | $1,773,000 | Mixed | 10 Jun 2026 | ||
| Marco Maria Brughera | Director | $1,698,494 | Mixed | 10 Jun 2026 | ||
| Jodi A. Cook | Director | $1,103,200 | Mixed | 10 Jun 2026 | ||
| Christiana Marie Cioffi | Chief Strategy Officer | $899,423 | Mixed | 31 Aug 2026 | ||
| Terry L. Evans | Chief Commercial Officer | $865,829 | Mixed | 31 Aug 2026 | ||
| Adrian Haigh | Chief Operating Officer | $832,168 | Mixed | 16 May 2024 | ||
| Pierre Sargis Sayad | Chief Medical Officer | $750,441 | -$146,160 | -16% | Mixed | 31 Aug 2026 |
| Shubh Goel | Chief Commercial Officer | Mixed | 20 Dec 2021 |
Recent insider transactions for FENNEC PHARMACEUTICALS INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Rosty Raykov | FENC | Common shares | Sale | -7.44% | $121,100 | $12.11 | -10,000 | 124,411 | 01 Sep 2026 | Direct |
| Rosty Raykov | FENC | Common shares | Award | 2.11% | 2,778 | 134,411 | 31 Aug 2026 | Direct | ||
| Pierre Sargis Sayad | FENC | Common Shares | Sale | -55.8% | $146,160 | $12.18 | -12,000 | 9,519 | 31 Aug 2026 | Direct |
| Pierre Sargis Sayad | FENC | Common Shares | Award | 0.79% | 168 | 21,519 | 31 Aug 2026 | Direct | ||
| Terry L. Evans | FENC | Common Shares | Award | 0.79% | 168 | 21,519 | 31 Aug 2026 | Direct | ||
| Christiana Marie Cioffi | FENC | Common shares | Award | 0.64% | 156 | 24,644 | 31 Aug 2026 | Direct | ||
| Jeffrey S. Hackman | FENC | Common Shares | Award | 1.78% | 1,159 | 66,302 | 31 Aug 2026 | Direct | ||
| Robert Andrade | FENC | Common shares | Award | 0.71% | 1,703 | 241,306 | 31 Aug 2026 | Direct | ||
| Robert Andrade | FENC | Common shares | Options Exercise | 10.1% | 21,928 | 239,603 | 28 Aug 2026 | Direct | ||
| Robert Andrade | FENC | Stock Options | Options Exercise | -2.74% | -21,928 | 779,330 | 28 Aug 2026 | Direct | ||
| Robert Andrade | FENC | Common shares | Sale | -25.6% | $883,500 | $11.78 | -75,000 | 217,675 | 27 Aug 2026 | Direct |
| Rosty Raykov | FENC | Common shares | Sale | -7.06% | $95,800 | $9.58 | -10,000 | 131,633 | 03 Aug 2026 | Direct |
| Pierre Sargis Sayad | FENC | Common Shares | Award | 0.79% | 168 | 21,351 | 31 Jul 2026 | Direct | ||
| Terry L. Evans | FENC | Common Shares | Award | 0.79% | 168 | 21,351 | 31 Jul 2026 | Direct | ||
| Christiana Marie Cioffi | FENC | Common shares | Award | 0.64% | 156 | 24,488 | 31 Jul 2026 | Direct | ||
| Jeffrey S. Hackman | FENC | Common Shares | Award | 1.81% | 1,159 | 65,143 | 31 Jul 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Award | 2% | 2,778 | 141,633 | 31 Jul 2026 | Direct | ||
| Robert Andrade | FENC | Common shares | Award | 0.59% | 1,703 | 292,675 | 31 Jul 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Sale | -6.47% | $99,926 | $10.41 | -9,599 | 138,855 | 01 Jul 2026 | Direct |
| Rosty Raykov | FENC | Common shares | Options Exercise | 11.7% | 15,597 | 148,454 | 01 Jul 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Award | 2.14% | 2,778 | 132,857 | 01 Jul 2026 | Direct | ||
| Rosty Raykov | FENC | Stock Options | Options Exercise | -1.01% | -15,597 | 1,525,000 | 01 Jul 2026 | Direct | ||
| Terry L. Evans | FENC | Common Shares | Award | 0.8% | 168 | 21,183 | 30 Jun 2026 | Direct | ||
| Pierre Sargis Sayad | FENC | Common Shares | Award | 0.8% | 168 | 21,183 | 30 Jun 2026 | Direct | ||
| Jeffrey S. Hackman | FENC | Common Shares | Award | 1.84% | 1,159 | 63,984 | 30 Jun 2026 | Direct | ||
| Robert Andrade | FENC | Common shares | Award | 0.59% | 1,703 | 290,972 | 30 Jun 2026 | Direct | ||
| Christiana Marie Cioffi | FENC | Common shares | Award | 0.65% | 156 | 24,332 | 30 Jun 2026 | Direct | ||
| Marco Maria Brughera | FENC | Stock Option | Award | 9.28% | 20,000 | 235,545 | 10 Jun 2026 | Direct | ||
| Jodi A. Cook | FENC | Stock Options | Award | 14.3% | 20,000 | 160,000 | 10 Jun 2026 | Direct | ||
| Khalid Islam | FENC | Stock Option | Award | 11.1% | 25,000 | 250,000 | 10 Jun 2026 | Direct | ||
| Chris A. Rallis | FENC | Stock Option | Award | 11.1% | 20,000 | 200,000 | 10 Jun 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Sale | -6.97% | $93,766 | $9.62 | -9,747 | 130,079 | 01 Jun 2026 | Direct |
| Rosty Raykov | FENC | Common shares | Options Exercise | 12.6% | 15,597 | 139,826 | 01 Jun 2026 | Direct | ||
| Rosty Raykov | FENC | Stock Options | Options Exercise | -0.99% | -15,597 | 1,556,195 | 01 Jun 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Award | 2.29% | 2,778 | 124,229 | 31 May 2026 | Direct | ||
| Christiana Marie Cioffi | FENC | Common shares | Award | 0.65% | 156 | 24,176 | 31 May 2026 | Direct | ||
| Terry L. Evans | FENC | Common Shares | Award | 0.81% | 168 | 21,015 | 31 May 2026 | Direct | ||
| Pierre Sargis Sayad | FENC | Common Shares | Award | 0.81% | 168 | 21,015 | 31 May 2026 | Direct | ||
| Jeffrey S. Hackman | FENC | Common Shares | Award | 1.88% | 1,159 | 62,825 | 31 May 2026 | Direct | ||
| Robert Andrade | FENC | Common shares | Award | 0.59% | 1,703 | 289,269 | 31 May 2026 | Direct | ||
| Chris A. Rallis | FENC | Common Shares | Sale | -11.7% | $58,756 | $7.04 | -8,346 | 63,077 | 11 May 2026 | Direct |
| Chris A. Rallis | FENC | Common Shares | Options Exercise | 25.1% | 14,344 | 71,423 | 11 May 2026 | Direct | ||
| Chris A. Rallis | FENC | Stock Option | Options Exercise | -7.15% | -14,344 | 186,189 | 11 May 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Sale | -8.15% | $69,753 | $6.47 | -10,781 | 121,451 | 01 May 2026 | Direct |
| Rosty Raykov | FENC | Common shares | Options Exercise | 13.4% | 15,598 | 132,232 | 01 May 2026 | Direct | ||
| Rosty Raykov | FENC | Stock Options | Options Exercise | -0.98% | -15,598 | 1,571,792 | 01 May 2026 | Direct | ||
| Rosty Raykov | FENC | Common shares | Options Exercise | 2.44% | 2,778 | 116,634 | 30 Apr 2026 | Direct | ||
| Terry L. Evans | FENC | Common Shares | Options Exercise | 0.81% | 168 | 20,847 | 30 Apr 2026 | Direct | ||
| Christiana Marie Cioffi | FENC | Common shares | Options Exercise | 0.65% | 155 | 24,020 | 30 Apr 2026 | Direct | ||
| Jeffrey S. Hackman | FENC | Common Shares | Options Exercise | 1.92% | 1,159 | 61,666 | 30 Apr 2026 | Direct |
* marks a reported price that did not pass the local price check.